Publication:
Belirgin kardiyovasküler hastalığı olmayan hastalarda COVID-19 mRNA aşısının elektrokar-diyografik parametreler üzerinde herhangi bir etkisi var mı?

Simple item page
dc.contributor.authorKEPEZ, ALPER
dc.contributor.authorTİGEN, ELİF
dc.contributor.authorsKüp A., Çelik M., Uslu A., Külahçıoğlu Ş., Tükenmez Tigen E., Demir S., Gülşen K., İzci S., Uygun Kızmaz Y., Kepez A.
dc.date.accessioned2022-10-04T11:29:04Z
dc.date.accessioned2026-01-11T17:14:41Z
dc.date.available2022-10-04T11:29:04Z
dc.date.issued2022-09-01
dc.description.abstractObjective: Electrocardiographic alterations were investigated following the second dosage of COVID-19 mRNA vaccination. Methods: A total of 260 individuals after two doses of COVID-19 vaccine with Pfizer-BioNTech were included in the study. The electrocardiographic parameters recorded at baseline and approximately one week later after two doses of Pfizer-BioNTech vaccine were compared for all patients. Results: PR interval was increased and QTc maximum interval was decreased significantly after second dose COVID-19 mRNA vaccination. Baseline and post-second dose vaccination states regarding P wave dispersion and QT dispersion/Tp-e interval which have been recognized to imply inhomogeneous atrial conduction and heterogeneity in ventricular repolarization were similar between groups. Conclusion: Our findings suggest that there should be no concern related to asymptomatic involvement of the myocardium subsequent the second dose of COVID-19 mRNA vaccination.
dc.identifier.citationKüp A., Çelik M., Uslu A., Külahçıoğlu Ş., Tükenmez Tigen E., Demir S., Gülşen K., İzci S., Uygun Kızmaz Y., Kepez A., "Belirgin kardiyovasküler hastalığı olmayan hastalarda COVID-19 mRNA aşısının elektrokar-diyografik parametreler üzerinde herhangi bir etkisi var mı?", Troia Medical Journal, cilt.3, sa.3, ss.96-99, 2022
dc.identifier.doi10.55665/troiamedj.1151301
dc.identifier.endpage99
dc.identifier.issn2630-6107
dc.identifier.issue3
dc.identifier.startpage96
dc.identifier.urihttps://hdl.handle.net/11424/282090
dc.identifier.volume3
dc.language.isotur
dc.relation.ispartofTroia Medical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectCardiovascular
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectTIP, GENEL & İÇECEK
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.subjectCARDIAC & CARDIOVASCULAR SYSTEMS
dc.subjectMEDICINE, GENERAL & INTERNAL
dc.subjectGenel Sağlık Meslekleri
dc.subjectPatofizyoloji
dc.subjectTemel Bilgi ve Beceriler
dc.subjectDeğerlendirme ve Teşhis
dc.subjectDahiliye
dc.subjectAile Sağlığı
dc.subjectKardiyoloji ve Kardiyovasküler Tıp
dc.subjectTıp (çeşitli)
dc.subjectGenel Tıp
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectFundamentals and Skills
dc.subjectAssessment and Diagnosis
dc.subjectInternal Medicine
dc.subjectFamily Practice
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectCOVID-19
dc.subjectmRNA vaccine
dc.subjectmyocarditis
dc.subjectelectrocardiography
dc.subjectP wave dispersion
dc.subjectQT dispersion
dc.subjectmRNA aşısı
dc.subjectmiyokardit
dc.subjectelektrokardiyografi
dc.subjectP dalga dispersiyonu
dc.subjectQT dispersiyonu
dc.titleBelirgin kardiyovasküler hastalığı olmayan hastalarda COVID-19 mRNA aşısının elektrokar-diyografik parametreler üzerinde herhangi bir etkisi var mı?
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
450.98 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları